Eng. J. Med. 316:889. 56. Rosenberg, S.A. 1988. The development of new immunotherapies for the treatment of cancer using interleukin-2. Ann. Surg. 208:121. 57. SC Yang, EA Grimm, DR Parkinson, J Carinhas, KD Fry, A Mendiguren-Rodriguez, J Licciardello, LB Owen- Schaub, WK Hong, and JA Roth. 1991. Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor-alpha in patients with advanced non-small cell lung cancer: a phase I trial. Cancer Res. 51:3669. 58. Oleksowicz L, Strack M, Dutcher JP, Sussman I, Caliendo G, Sparano J, Wiernik PH. 1994. A distinct coagulopathy associated with interleukin-2 therapy.Br. J. Haematol. 88:892. 59. Rosenberg SA, Lotze MT, Muul LM, et. Al.